Company: ARVN
Filing Date: 2025-08-06
Form Type: 10-Q
Source: 0001655759-25-000139
Chunk: 98

Company: ARVINAS, INC.
Filing Date: 2025-08-06
Form: 10-Q
Item: Part I, Item 1
Chunk 98
---
 exercise price)Options Weighted AverageExercise PriceWeighted AverageRemaining ContractualTerm (Years)Aggregate Intrinsic ValueOutstanding as of December 31, 20247,892,330 $44.16 6.7$3.2 Granted2,165,498 $12.54 Cancelled/ Forfeited(503,870)$44.26 Outstanding as of June 30, 20259,553,958 $37.31 6.9$0.6 Vested and exercisable as of June 30, 20256,195,452 $45.06 5.7$— Vested and expected to vest as of June 30, 20259,212,437 $37.99 6.8$0.5 

15

The weighted-average grant date fair value per share of options granted during the six months ended June 30, 2025 and 2024 was $12.54 and $28.08, respectively. There were no options exercised during the six months ended June 30, 2025. The total intrinsic value of options exercised during the six months ended June 30, 2024 was $3.5 million.Restricted Stock Units ("RSUs")A summary of RSU activity during the six months ended June 30, 2025 is presented below. Included in the table are RSUs granted to employees and directors under the 2018 Plan, as well as RSUs representing 170,365 shares of common stock granted to certain employees pursuant to the Nasdaq inducement grant exception in accordance with Nasdaq Listing Rule 5635(c)(4).Shares Weighted AverageGrant DateFair Value PerShareUnvested RSUs as of December 31, 20242,311,291 $42.25 Granted3,382,825 $13.98 Vested(911,874)$43.82 Cancelled / Forfeited(628,701)$26.91 Unvested RSUs as of June 30, 20254,153,541 $21.28 The weighted-average grant date fair value per share of RSUs granted during the six months ended June 30, 2025 and 2024 was $13.98 and $44.98, respectively. The total intrinsic value of RSUs released during the six months ended June 30, 2025 and 2024 was $14